Related Experiment Video
Updated: Aug 13, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
HER-2/neu (erbB-2) and the cell cycle
D Busse1, R S Doughty, C L Arteaga
1Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Abstract:
Signaling by the HER-2 proto-oncogene product results in the activation of several biochemical pathways, which in turn modulate the expression and function of cell cycle regulators. These alterations of cell cycle regulatory molecules may be critical for the conception and maintenance of the transformed phenotype conferred by HER-2 gene amplification and overexpression. On the other hand, blockade of HER-2 function with a therapeutic intent will require the reversal of these effects on cell cycle regulatory molecules in order for these interventions to be effective. Data is presented to suggest that the G1 cyclin D1 and the cyclin-dependent kinase inhibitor p27KIP1 may be involved in subversion of the G1/S traverse by signaling pathways activated by HER-2 function.
Insights
HER-2 proto-oncogene signaling activates pathways affecting cell cycle regulators, potentially driving cancer. Targeting HER-2 may require reversing these effects, with cyclin D1 and p27KIP1 implicated in cell cycle disruption.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- HER-2 proto-oncogene amplification and overexpression are linked to various cancers.
- HER-2 signaling influences cell cycle progression, contributing to cellular transformation.
- Therapeutic strategies targeting HER-2 require understanding its impact on cell cycle regulation.
Purpose of the Study:
- To investigate the role of HER-2 signaling in modulating cell cycle regulators.
- To identify specific molecules involved in HER-2-mediated cell cycle subversion.
- To explore potential mechanisms for reversing HER-2 effects for therapeutic benefit.
Main Methods:
- Analysis of signaling pathways activated by HER-2.
- Examination of the expression and function of cell cycle regulators.
- Investigation of the involvement of cyclin D1 and p27KIP1 in HER-2 signaling.
Main Results:
- HER-2 signaling activates biochemical pathways that alter cell cycle regulators.
- These alterations are critical for the transformed phenotype associated with HER-2.
- Cyclin D1 and p27KIP1 appear to be involved in disrupting the G1/S cell cycle transition via HER-2 pathways.
Conclusions:
- HER-2 signaling profoundly impacts cell cycle control, promoting cancer phenotypes.
- Understanding these molecular alterations is crucial for effective HER-2 targeted therapies.
- Cyclin D1 and p27KIP1 are key players in HER-2-driven cell cycle dysregulation.
More Related Videos
12:02Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
08:28Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
Related Concept Videos
What is the Cell Cycle?
Negative Regulator Molecules
Mitogens and the Cell Cycle
What is the Cell Cycle?
Mitogens and the Cell Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...